Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
2
67%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

unknown267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_2

Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression

NCT03349528
unknownphase_2

Synbiotic Compound to Reduce Symptoms of Schizophrenia

NCT04226898
completednot_applicable

Probiotics to Prevent Relapse After Hospitalization for Mania

NCT01731171

Clinical Trials (3)

Showing 3 of 3 trials
NCT03349528Phase 2

Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression

Unknown
NCT04226898Phase 2

Synbiotic Compound to Reduce Symptoms of Schizophrenia

Unknown
NCT01731171Not Applicable

Probiotics to Prevent Relapse After Hospitalization for Mania

Completed

All 3 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
3